Cytoplasmic nucleophosmin in myeloid sarcoma occurring 20 years after diagnosis of acute myeloid leukaemia

被引：22

作者：

Bolli, N

Galimberti, S

Martelli, MP

Tabarrini, A

Roti, G

Mecucci, C

Martelli, MF

Petrini, M

Falini, B ^{[1
]}

机构：

[1] Monteluce Policlin, Inst Haematol, I-06122 Perugia, Italy

[2] Policlin S Chiara, Inst Haematol, Pisa, Italy

来源：

LANCET ONCOLOGY | 2006年 / 7卷 / 04期

关键词：

D O I：

10.1016/S1470-2045(06)70661-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：350 / 352

页数：3

共 11 条

[1] Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance [J].

Alcalay, M ;

Tiacci, E ;

Bergomas, R ;

Bigerna, B ;

Venturini, E ;

Minardi, SP ;

Meani, N ;

Diverio, D ;

Bernard, L ;

Tizzoni, L ;

Volorio, S ;

Luzi, L ;

Colombo, E ;

Lo Coco, F ;

Mecucci, C ;

Falini, B ;

Pelicci, PG .

BLOOD, 2005, 106 (03) :899-902

[2] Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype [J].

Boissel, N ;

Renneville, A ;

Biggio, V ;

Philippe, N ;

Thomas, X ;

Cayuela, JM ;

Terre, C ;

Tigaud, I ;

Castaigne, S ;

Raffoux, E ;

De Botton, S ;

Fenaux, P ;

Dombret, H ;

Preudhomme, C .

BLOOD, 2005, 106 (10) :3618-3620

[3] Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype [J].

Cazzaniga, G ;

Dell'Oro, MG ;

Mecucci, C ;

Giarin, E ;

Masetti, R ;

Rossi, V ;

Locatelli, F ;

Martelli, MF ;

Basso, G ;

Pession, A ;

Biondi, A ;

Falini, B .

BLOOD, 2005, 106 (04) :1419-1422

[4] Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics:: interaction with other gene mutations [J].

Döhner, K ;

Schlenk, RF ;

Habdank, M ;

Scholl, C ;

Rücker, FG ;

Corbacioglu, A ;

Bullinger, L ;

Fröhling, S ;

Döhner, H .

BLOOD, 2005, 106 (12) :3740-3746

[5] Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. [J].

Falini, B ;

Mecucci, C ;

Tiacci, E ;

Alcalay, M ;

Rosati, R ;

Pasqualucci, L ;

La Starza, R ;

Diverio, D ;

Colombo, E ;

Santucci, A ;

Bigerna, B ;

Pacini, R ;

Pucciarini, A ;

Liso, A ;

Vignetti, M ;

Fazi, P ;

Meani, N ;

Pettirossi, V ;

Saglio, G ;

Mandelli, F ;

Lo-Coco, F ;

Pelicci, P ;

Martelli, MF .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) :254-266

[6]

FALINI B, 2006, BLOOD, DOI DOI 10.1182/BLOO-2005-11-4745

[7]

Jaffe ES., 2001, PATHOLOGY GENETICS T

[8]

Schiffer CA, 1997, CANCER-AM CANCER SOC, V80, P2210

[9] Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype [J].

Schnittger, S ;

Schoch, C ;

Kern, W ;

Mecucci, C ;

Tschulik, C ;

Martelli, MF ;

Haferlach, T ;

Hiddemann, W ;

Falini, B .

BLOOD, 2005, 106 (12) :3733-3739

[10] Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia [J].

Suzuki, T ;

Kiyoi, H ;

Ozeki, K ;

Tomita, A ;

Yamaji, S ;

Suzuki, R ;

Kodera, Y ;

Miyawaki, S ;

Asou, N ;

Kuriyama, K ;

Yagasaki, F ;

Shimazaki, C ;

Akiyama, H ;

Nishimura, M ;

Motoji, T ;

Shinagawa, K ;

Takeshita, A ;

Ueda, R ;

Kinoshita, T ;

Emi, N ;

Naoe, T .

BLOOD, 2005, 106 (08) :2854-2861

← 1 2 →